With over 20 years in the pharma/biotech industry, Sara has extensive Global Rare Disease expertise spanning several therapeutic areas and functions (sales, training, marketing, management, alliances, business development, portfolio strategy, global leadership). She has a true passion for the rare disease space as evidenced by her success.
Sara most recently served as Senior Vice President, Commercial, Global Strategy for Ultragenyx Pharmaceuticals, based in Basel, Switzerland. Prior to that, Sara held multiple roles with advancing leadership responsibility with Shire (2007-2016), her most recent as Vice President, Product Strategy Lead, for both the GI and LSD-MPS II Franchises based in the US and also Switzerland. Prior to joining Shire, Sara worked at Astellas, Sanofi and Bayer, all based in the US. Sara holds a B.A. from the University of Nebraska-Lincoln and Executive Education from both Harvard School of Public Health and Columbia Business School.
Key Accomplishments